Companies:
53,025
Total Market Cap:
169002833548104.08
ProPhase Labs
NASDAQ: PRPH
Healthcare
Diagnostics & Research
Global Rank
#49775
Country Rank
#6001
Market Cap
1.19 M
Price
0.257
Change (%)
29.21%
Volume
1.11 M
ProPhase Labs's latest marketcap:
1.19 M
As of 01/05/2026, ProPhase Labs's market capitalization has reached $1.19 M. According to our data, ProPhase Labs is the 49775th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.19 M |
| Revenue (ttm) | 5.06 M |
| Net Income (ttm) | -41,704,000 |
| Shares Out | 4.62 M |
| EPS (ttm) | -11.64 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/24/2022 |
| Earnings Date | 11/19/2025 |
Market Cap Chart
Data Updated: 01/05/2026
ProPhase Labs's yearly market capitalization.
ProPhase Labs has seen its market value drop from $72.7 M to $2.1 M since 1998, representing a total decrease of 97.11% and an annual compound decline rate (CAGR) of 12.30%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 12/31/2025 | $2.1 M | -88.4% | 36752 |
| 12/31/2024 | $18.1 M | -77.82% | 34801 |
| 12/29/2023 | $81.6 M | -47.96% | 24417 |
| 12/30/2022 | $156.8 M | 41.01% | 19479 |
| 12/31/2021 | $111.2 M | 4.41% | 22448 |
| 12/31/2020 | $106.5 M | 367.11% | 20250 |
| 12/31/2019 | $22.8 M | -37.36% | 25851 |
| 12/31/2018 | $36.4 M | 34.81% | 22649 |
| 12/29/2017 | $27 M | -21.05% | 24379 |
| 12/30/2016 | $34.2 M | 33.59% | 21142 |
Company Profile
ProPhase Labs was founded in 1989 in United States.
The company went public on 01/16/1997
on the Nasdaq Stock Market.
With 96 employees, it focuses on Healthcare and aims to drive innovation in Diagnostics & Research.
Frequently Asked Questions
-
What is ProPhase Labs's (PRPH) current market cap?As of 01/05/2026, ProPhase Labs (including the parent company, if applicable) has an estimated market capitalization of $1.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ProPhase Labs (PRPH) rank globally by market cap?ProPhase Labs global market capitalization ranking is approximately 49775 as of 01/05/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.